May 16, 2012 – Silicon Bayou News
NuMe Health, the New Orleans-based biotech startup developing products that modify the bacteria that live in the gastrointestinal tract, today announced that it has closed a $1.5 million Series A financing.
NuMe Health Lands 1.5m Series A
Related Articles
Meet NOBIC at BIO in San Diego June 22nd- June 25th
The NOBIC team is headed to BIO in San Diego June 22 - June 25. We will be engaging with neuroscience startups for BioChallenge 2026 and meeting up with companies…
Beken Bio Announces Lab Expansion at New Orleans BioInnovation Center
FOR IMMEDIATE RELEASE Beken Bio Announces Lab Expansion at New Orleans BioInnovation Center, advancing ovarian cancer detection efforts New CLIA-certified lab marks milestone toward commercialization of breakthrough blood test NEW…
CDVCA and New Orleans BioFund co-invest to advance bioscience innovation and economic opportunity in New Orleans
For Immediate Release CDVCA and New Orleans BioFund co-invest to advance bioscience innovation and economic opportunity in New Orleans NEW ORLEANS (March 3, 2026) — The Community Development Venture Capital Alliance…